Tocriscreen Library of FDA-Approved Compounds

Biological Activity

A library of 159 compounds supplied pre-dissolved in DMSO (250 μL 10 mM solution). Contains compounds covering a range of therapeutic classes e.g. the cardiovascular and nervous systems and research areas such as cancer and immunology. Includes both established gold-standard compounds, e.g. tamoxifen, paclitaxel, as well as more recent highly selective, targeted compounds, such as gefitinib and axitinib.

Key Format and Product Details

Request Compound List

A list of the compounds available in the Tocriscreen Library of FDA-Approved Compounds can be requested in Excel or SD format via our Tocriscreen & Custom Library Inquiries form.

Technical Data

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.

Additional Information

Background References

1. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
   Li et al.
   Cell Research, 2011;21:196
2. Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis.
   Hattori et al.
   Proc.Natl.Acad.Sci.USA, 2010;107:3546
3. The University of New Mexico Center for Molecular Discovery.
   Edwards et al.
   Comb.Chem.High Throughput Screen., 2014;17:256
4. Small-molecule-driven direct reprogramming of mouse fibroblasts into functional neurons.
   Li et al.
   Cell Stem Cell, 2015;17:195
5. Small molecules enhance CRISPR genome editing in pluripotent stem cells.
   Yu et al.
   Cell Stem Cell, 2015;16:142
6. Cell-based potassium ion channel screening using the FluxORTM assay.
   Beacham et al.
   J.Biomol.Screen., 2010;15:44

Product Datasheets